Chapter 947 Hitting the bottom

"At present, China has announced the punishment of GlaxoSmithKline, and issued a fine of 3 billion Chinese yuan to them. This is also the highest fine ever issued by China against a company..."

Daisy elegantly pushed the gold-rimmed glasses she was wearing and continued:

"With the release of this result, GlaxoSmithKline's stock price continued to fall after the opening, and has now fallen by nearly 5%."

"We can take this opportunity to close our positions and buy some GSK (GlaxoSmithKline) stocks."

"I think so too, and we have already started buying."

Although the 3 billion Chinese yuan fine issued by China to GlaxoSmithKline seems to be a lot.

But you have to know that last year, in 2012, GlaxoSmithKline also paid 3 billion... but in US dollars!

This is also the largest settlement case in history so far.

The U.S. Department of Justice said at the time that GlaxoSmithKline pleaded guilty to three criminal charges and was suspected of bribing doctors in the United States with luxury trips to Hawaii and academic lectures with a million-dollar salary to prescribe the company's products to patients.

At that time, GlaxoSmithKline's CEO Andrew Witty said afterwards, "We have learned from our mistakes."

Well, from the perspective of Huaxia, GlaxoSmithKline still hasn't learned thoroughly enough.

But now, Huaxia's "boots landing" also means that the biggest negative news for GlaxoSmithKline in these events has been determined-although it will inevitably affect GlaxoSmithKline's stock price again, but after that, there is a possibility of bottoming out.

This is why Barron and Daisy both believe that their short positions on GlaxoSmithKline's stock price can be closed, and the profits can be used to continue to absorb its stocks.

At present, GlaxoSmithKline's market value has fallen from last year's high of more than $120 billion to less than $80 billion.

According to calculations, DS Group's short-selling of GlaxoSmithKline's stock price will eventually generate a profit of about $8 billion.

This means that if these profits are invested in the acquisition of its stocks, nearly 10% of GlaxoSmithKline's shares can be obtained.

However, in reality, it is not calculated this way.

Although GlaxoSmithKline's market value is less than $80 billion now, as they close their positions and absorb GlaxoSmithKline's stocks later, with the amount of funds involved, it will inevitably rise sharply.

Therefore, even if all the $8 billion in profits are invested, according to estimates, about 8-8.5% of the shares can be obtained, and the specific proportion depends on the market situation.

As for buying GlaxoSmithKline's shares from some institutions?

This is of course possible, but it is definitely impossible to buy at the current price-those institutions will not be so happy to cut their losses. Since Daisy can see that GlaxoSmithKline's stock price may have bottomed out, those institutions naturally cannot fail to see it.

DS Group was able to successfully short GlaxoSmithKline's stock price. The difference was that they had already set up a position before this "sudden" incident...

What if things changed, and GlaxoSmithKline's bribery in China did not break out on time like in the original time and space?

Such a large-scale shorting has already begun to be arranged. If this incident did not happen, Barron would not hesitate to send someone to report it directly to China...

After all, with the current amount of funds invested by DS Group, it is rare to be able to target a company. Only those large companies with a market value of more than 100 billion are possible.

Such an opportunity is rare, and it is naturally impossible to miss it.

...

On September 20, Hangyu Seiko officially released the latest drone in the Hummingbird series, the HUM-2 drone.

This is also the third Hummingbird series drone launched by Hangyu Seiko-they launched the HUM-1 and HUM-1 Pro Hummingbird series drones last year and early this year, respectively, and both received good responses.

Especially HUM-1 Pro, which has upgraded the performance of the first generation HUM-1 drone, and optimized the controllability and flight posture, but the price is only 11, which has also increased the sales of HUM-1 Pro.

However, compared with the previous two hummingbird drones, the launch of HUM-2 is subversive.

Not only has HUM-2 continued to improve its performance, but it is also equipped with a high-definition lens like the Phantom series drones launched by its competitor DJI, which can be said to have greatly improved its cost performance.

Thanks to the establishment of an advanced "robot production workshop" in Birmingham by Hangyu Seiko, and the fact that most of its accessories have also obtained long-term partners in China, its cost control has made great progress.

Of course, this is also related to the scale advantage that Hangyu Seiko has gained in the supply chain after the first two Hummingbird series drones, which has reduced procurement costs.

In the end, under the premise of greatly improved performance, the price of HUM-2 was directly reduced to 1,599 euros, which was able to compete with DJI's Phantom series drones.

Therefore, on the day when the HUM-2 drone of Hangyu Seiko was put on sale, users lined up to buy it at the entrance of Hangyu Seiko experience stores in London and New York.

As mentioned before, the HUM (Hummingbird) series is the entry-level drone product model of Hangyu Seiko for families and non-professional groups, and its main feature is easy operation and easy to carry.

In addition, Hangyu Seiko also launched the first product of the Griffin (Lion Heron) series of drones, G1, at the end of last year.

The G1 is larger and can carry professional camera equipment, so it is popular among professional photographers.

After all, before this, if you need aerial photography, you often need to use helicopters or hot air balloons to shoot, which is not only expensive, but also has its own limitations.

But the emergence of DJI's Hot Wheels and Hangyu Seiko G1 has made aerial photography a more convenient choice for film and television crews and travel photography teams.

The second product of the Griffin series of Hangyu Seiko, G2, will also be launched around Christmas. For this purpose, they will also build a new "robot production line" at the Hangyu Seiko manufacturing base in Birmingham...

Currently, Hangyu Seiko's two main rotor unmanned products are the Hummingbird series and the Griffin series. In the future, they will maintain the rhythm of launching 1-2 new products each year.

For this reason, Hangyu Seiko continues to expand the scale of their R\u0026D center in London, recruiting more technicians and professionals to reserve technology and talents.

There is no doubt that after the launch of the HUM-2 drone, Barron's children will get their new toys again...